The objectives and specific aims of this proposal are to develop improved assays for both the detection of antibodies against HTLV-I, HTLV-II and HIV-2 antigens and also the detection, characterization, and quantification of the proteins and nucleic acids of these same viruses. All assays will make use of previously accrued and well-characterized bank of over 20,000 human sera and cells to facilitate assessment of sensitivity and specificity. Serological assays will be designed to detect either IgG or IgM reactivities. Assay formats will involve a variety of sources of viral antigen including purified virions, synthetic peptides and recombinant proteins.
The aim will be to develop ELISA, western blots and/or immunoblots that are sensitive and specific enough to obviate the need for RIPA's. Protein detection will center on the development of polyclonal and monoclonal antibodies to be used in direct cell staining or antigen capture assay formats. Antibodies will be made against all major structural, functional, and regulatory viral proteins. Nucleic acid studies will center on the continued development of the PCR and QB replicase system for the detection, quantification and sequencing of specific viral DNA and RNA from human tissues and body fluids. It is anticipated that the above techniques will make their way into clinical systems for the prevention, diagnosis and treatment of human retroviral disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL043602-03
Application #
3362279
Study Section
Special Emphasis Panel (SRC (CN))
Project Start
1989-09-15
Project End
1992-07-31
Budget Start
1991-09-01
Budget End
1992-07-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Upstate Medical University
Department
Type
Schools of Medicine
DUNS #
058889106
City
Syracuse
State
NY
Country
United States
Zip Code
13210
Dube, Syamalima; Saksena, Nitin; Spicer, Timothy et al. (2013) Delayed seroconversion to STLV-1 infection is associated with mutations in the pol and rex genes. Virol J 10:282
Gavalchin, J; Fan, N; Waterbury, P G et al. (1995) Regional localization of the putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3. Virology 212:196-203
Sherman, M P; Amin, R M; Rodgers-Johnson, P E et al. (1995) Identification of human T cell leukemia/lymphoma virus type I antibodies, DNA, and protein in patients with polymyositis. Arthritis Rheum 38:690-8
Saksena, N K; Herve, V; Durand, J P et al. (1994) Seroepidemiologic, molecular, and phylogenetic analyses of simian T-cell leukemia viruses (STLV-I) from various naturally infected monkey species from central and western Africa. Virology 198:297-310
Coyle, T E; Spicer, T; Michalovic, D et al. (1994) Moderate hemophilia B Leyden: identification by polymerase chain reaction, sequencing, and oligomer restriction. Am J Hematol 46:234-40
Dosik, H; Goldstein, M F; Poiesz, B J et al. (1994) Seroprevalence of human T-lymphotropic virus in blacks from a selected central Brooklyn population. Cancer Invest 12:289-95
Glaser, J B; Levis, W R; Gruber, T et al. (1994) Prevalence of human T cell lymphotropic virus (HTLV) types I and II and human immunodeficiency virus type 1 infections among persons with Hansen's disease in New York City. J Infect Dis 170:1007-9
Sullivan, M T; Williams, A E; Fang, C T et al. (1993) Human T-lymphotropic virus (HTLV) types I and II infection in sexual contacts and family members of blood donors who are seropositive for HTLV type I or II. American Red Cross HTLV-I/II Collaborative Study Group. Transfusion 33:585-90
Sherman, M P; Dube, S; Spicer, T P et al. (1993) Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-asso Cancer Res 53:6067-73
Dube, D K; Sherman, M P; Saksena, N K et al. (1993) Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II. J Virol 67:1175-84

Showing the most recent 10 out of 23 publications